Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Complete Mivtach Shamir Holdings Ltd. stock information by Barron's. View real-time MISH stock price and news, along with industry-best analysis.

M*A*S*H remains one of the most iconic and influential shows in television history; the series, which followed a rag-tag group of army doctors during the Korean War, premiered in 1972 and ran for 11 ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...